Clinical Trials Logo

Technology clinical trials

View clinical trials related to Technology.

Filter by:

NCT ID: NCT05302440 Completed - Technology Clinical Trials

The Perceived Efficiency and Acceptability of Remote Real-time Health Monitoring System With Ring-like Sensor in Elderly Residential Setting

Start date: March 21, 2022
Phase:
Study type: Observational [Patient Registry]

The study has 3 primary research questions and 6 secondary research questions targeting care staff in the setting of residential care homes for the elderly. The 3 primary research questions are: 1. Will care staff perceive the remote real-time health monitoring system with ring-like sensor as efficient? 2. Will the system facilitate any early detection of abnormal vital signs? 3. Will the system facilitate early delivery of medical support? The 6 secondary research questions are: 4. What are the numbers of hospital admissions and further medical assistance due to the adoption of the system? 5. Will the system reduce the stress level of the care staff? 6. What are the perceived benefits and acceptability of the care staff towards the system? 7. What should be considered when developing the evaluation framework for the adaption of the system in elderly residential setting? 8. Are there any barriers and difficulties in the set-up of the system? 9. What are the concerns in choosing wireless or cable connection for the monitoring device?

NCT ID: NCT05293756 Recruiting - Hypertension Clinical Trials

OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)

Start date: February 14, 2021
Phase: N/A
Study type: Interventional

Hypertension (HTN) has a greater impact on African Americans (AA) than any other U.S. racial group. Uncontrolled blood pressure (BP) contributes to higher rates of disability, death, and health resource use among AA. HTN is the single most influential risk factor for cardiovascular disease (CVD), as well as a risk factor for the incidence of stroke, diabetes, chronic kidney disease, and dementia. Importantly, older adults account for 15% of the U.S. population, and two-thirds of older adults over age 60 have HTN, with higher rates observed in AA older adults. Strategies to support self-managing HTN and BP control are crucial as the older population is projected to age considerably and become more racially and ethnically diverse. Research has documented the negative effects on health and health outcomes of poorly controlled BP and is one of the most important modifiable CVD risk factors. Lower BP targets will require aggressive management and an increase in antihypertensive medications. Therefore, to achieve lower targets in this population, greater efforts, including patient-centered methods will be needed to support self-managing HTN, especially in terms of medication adherence. As we shifted into the digital age, the use of mHealth technologies (smart phones, applications, SMS or text messaging) has been a powerful approach and mechanism for the treatment and management of chronic diseases. However, behavioral interventions that incorporate technology do not reach minorities or disadvantaged AA older adults with HTN. OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP) will leverage existing knowledge of effective technology-based components for HTN self-management to support and improve BP control using unique aspects of mHealth platforms in AA older adults. Findings from this study, if confirmed, will improve BP control and support self-managing HTN, as well as has the potential to close the health disparity gap between AA and non-AA older adults with HTN.

NCT ID: NCT05086757 Recruiting - Clinical trials for Posttraumatic Stress Disorder

Evaluation of Trauma Center-Based Intervention for Adolescent Traumatic Injury Survivors

Start date: July 1, 2022
Phase: N/A
Study type: Interventional

Pediatric traumatic injury (i.e., injury of sudden onset and severity requiring immediate attention) is the leading cause of death and morbidity among US adolescents and are associated with mental health and health risk outcomes, including posttraumatic stress and depression (affecting between 19-42%), deficits in physical recovery, social functioning and quality of life, which if unaddressed, may contribute to increased use of health care services. The investigators partnered with three accredited Level I and II pediatric trauma centers to conduct a multi-site hybrid 1 effectiveness-implementation trial with 300 adolescent (ages 12-17) traumatic injury patients to assess the extent to which the Trauma Resilience and Recovery Program (TRRP), a scalable and sustainable, technology-enhanced, multidisciplinary stepped model of care, promotes improvement in quality of life and emotional recovery and gather preliminary data on the potential for TRRP to be implemented in other Level I trauma centers. Directly in line with NICHD's Pediatric Trauma and Critical Illness Research and Training (PTCIB) Strategic Research and Training agenda, this study will provide valuable data on the efficacy, preliminary effectiveness and potential for implementation of an innovative, cost-effective, sustainable technology-enhanced intervention designed to address the unique needs of adolescent injury patients and mitigate short- and long-term impact of injury on mental health, quality of life, and overall well-being.

NCT ID: NCT04962191 Recruiting - Lung Cancer Clinical Trials

Idylla EGFR Lung Trial

Start date: August 2021
Phase:
Study type: Observational

This retrospective, observational study will compare the results of a BioCartis' EGFR mutation test on the Idylla platform with test results from SoC pathology results from tissue biopsies in the same setting. A comparable rapid testing platform for EGFR may serve as a more accessible means to diagnose, and overall, more patients treated successfully with targeted therapies. Up to 150 samples will be tested and compared with existing results.

NCT ID: NCT04878965 Active, not recruiting - Technology Clinical Trials

Smartwatches to Manage Stress and Anxiety in Residential Settings

Smartwatch
Start date: April 26, 2021
Phase: N/A
Study type: Interventional

The purpose of the study is to conduct a prospective evaluation of a smartwatch technology and an associated application (developed by Awake Labs) in a clinical cohort from Centre for Addiction and Mental Health (CAMH) Adult Neurodevelopmental Services (ANS) and adults with developmental disabilities in the community who have received a watch.

NCT ID: NCT04730960 Completed - Neck Pain Clinical Trials

Comparison of Cervical Region Characteristics of People With Smartphone Addiction

Start date: January 15, 2021
Phase:
Study type: Observational

In healthy participantsng adults, the anterior tilt position of the head and consequently flattening of the cervical lordosis may results in impaired neutral posture of the spine during daily long-term computer etc. use with today's technology. In addition, the increasing use of smart phones may also promote this negative results. According to a study, the estimated total smartphone sales for 2012 was 660 million, but as of 2015, it is estimated that a total of one billion units worldwide. It is also thought that phone sales will continue to increase over the years, as it facilitates daily life activities. As a result of our literature review, the investigators have not come across a study that evaluates demographic information such as the duration of using smartphones or computers, cervical position sense, neck muscle strength, physical activity and general psychological status, which the investigators think may affect the performance of deep cervical flexor muscles in healthy participantsng adults. With this study, it will be ensured that more information about the factors affecting the performance of deep cervical flexor muscles will be determined in advance and necessary steps will be taken to prevent the factors that may cause neck problems in the future.

NCT ID: NCT04634851 Not yet recruiting - Diet Habit Clinical Trials

Video Home Visits for Dietary Counselling

Start date: July 1, 2027
Phase: N/A
Study type: Interventional

This pilot study aims to develop a protocol for home video informed dietary counseling with the goal of reducing overall sodium consumption among kidney stone formers. To accomplish this the investigators will: 1)Assess which data available on video visits are most informative to convey patient sodium consumption, and 2) Administer virtual home visits with informed dietary counseling in our intervention arm and compare this to standard dietary counseling looking specifically at the outcome of 24-hour urine sodium excretion results over time. This study will benefit dramatically from the rapid growth of telehealth medical visits as a consequence of the SARS-CoV-2 pandemic, with the ultimate goal to improve and adapt patient dietary counseling for the prevention of kidney stone disease in the new and evolving era of telehealth.

NCT ID: NCT04632186 Recruiting - Stroke Clinical Trials

Development of an Electronic Suit to Reduce Hemiplegic Shoulder Pain

Start date: August 9, 2020
Phase: N/A
Study type: Interventional

In an innovative approach, a full body suit with multiple electrodes for provision off electrical stimulation has been developed by a Swedish Med-tech company. Based on theoretical background and clinical experience, this study will explore the potential value of the EXOPULSE Mollii suit-method in the management of post stroke shoulder pain. The overall aim of this study is to test and further develop the Mollii-suit for its ability to reduce hemiplegic shoulder pain. The specific aims are 1) to compare the effect of different stimulation modes for shoulder pain reduction 2) to explore which patients will respond best to these.

NCT ID: NCT04534335 Completed - Clinical trials for Congenital Heart Disease

SNOO Smart Sleeper for Infants With CHD

SHHH's
Start date: February 4, 2020
Phase:
Study type: Observational

Study Title The SSSH Study: SNOO Smart Sleeper Use in Post-Operative Infants with Congenital Heart Disease is a single site, cross-sectional, feasibility study of an infant smart sleeper. The Primary Objective is to evaluate the feasibility of collecting and integrating clinical data and SNOO data. The secondary Objective(s) is To assess the feasibility of conducting a future broader trial by evaluating the parents willingness to give parental permission for participation in the use of the SNOO. Research Intervention(s)/ Investigational Agent(s) SNOO Smart Sleeper from Happiest Baby, Inc.There are approximately 300 new infants per year who undergo cardiac surgery at Children's Mercy Kansas City (CMKC) who are 6 months of age and 11kg or less at the time of surgery Sample Size. A maximum of 15 patients will be enrolled for this feasibility study over the study Duration for Individual Participant Length of hospitalization on 4Sutherland, average length of stay for this patient population is 30 days.

NCT ID: NCT04396392 Active, not recruiting - Mental Health Issue Clinical Trials

VR-based Exposure Training for Adolescents With Fear of Public Speaking

Start date: March 1, 2020
Phase: N/A
Study type: Interventional

Public speaking anxiety (PSA) is a common anxiety with onset in adolescence and early adulthood. With the advent of consumer Virtual Reality (VR) technology, VR-delivered exposure therapy has previously been shown to be efficacious with adults. Virtual reality has existed for several decades, but it is only in the recent years it has become readily available. The new generation of off-the-shelf, consumer VR hardware, can revolutionize the design, availability and dissemination of VR therapist tools for exposure therapies. Importantly, there has been relatively little research on VR delivered exposure of anxiety in social situations compared to other anxiety disorders, presumably due to the complexity of the virtual stimuli required. There has been no study on VR delivered exposure specifically for adolescents until recently. A feasibility and pilot trial laying the foundation of the current study showed great potential in using VR for adolescents with PSA. The current study aims to investigate the efficacy of a self-guided VR intervention compared to a self-guided internet-delivered text-based intervention using a two-phased randomized design. Adolescents aged 13-16 will be invited to participate in the study